Does PayPal Have a Buyer?

In this episode of Motley Fool Hidden Gems Investing, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rachel Warren discuss:

• PayPal’s offer.
• How Stripe gets a deal done.
• Why PayPal says “no.”
• J&J’s earnings.
• Uber in D.C.
• How Uber became the incumbent.

To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When you're ready to invest, check out this top 10 list of stocks to buy.

A full transcript is below.

This podcast was recorded on July 15, 2026.

Travis Hoium: PayPal may finally have a buyer. Motley Fool Hidden Gems Investing starts now. Welcome to Motley Fool Hidden Gems Investing. I'm Travis Hoium, joined today by Lou Whiteman and Rachel Warren, and guys, we may finally have a deal for the company that has been on the block, a value stock. What in the world are they doing there? PayPal. Rachel, what did we find out this morning and overnight about Stripe potentially buying the company?

Rachel Warren: Major breaking news reports. Payments giant Stripe and private equity firm Advent International have reportedly submitted a joint confidential proposal to buy PayPal for $60.50 a share. That would value PayPal at over $53 billion. As of the stock's closing price yesterday, that was a 28% premium based on their share price at the time. The deal is reportedly backed by about $50 billion in committed bank financing. Now, what's interesting about this is under the terms of the proposal, both Stripe and Advent would take equal stakes to run PayPal as a 50/50 joint partnership, and the idea would be to keep the company intact rather than breaking it up or selling off its core assets. Back to that $53 billion valuation based on the reported terms of the offer.

This is tracking to be larger than the years ago Musk's purchase of Twitter for 44 billion, but it also really highlights how far PayPal has fallen from its pandemic-era peak back in 2021. Back in those days, it posted a market cap of about $360 billion. This is interesting. This is in the middle of what some might call a chaotic internal transition for PayPal. They've got the new president and CEO. He's been pushing a turnaround plan targeting over 1 billion in cost savings.

Now, for Stripe, this is still a private company. We've heard a lot of reports that they might go public in the last few years. Their private valuation is reportedly around $160 billion. Absorbing PayPal could really be a massive way to scale their footprint. Obviously, grants them access to hundreds of millions of active consumer accounts; it would match that consumer brand that PayPal has, with Stripe's backend developer infrastructure could also hand them a place within the digital currency race as they absorb PayPal's stablecoin into their ecosystem. Now, we haven't seen any response from PayPal formally responding to these initial overtures. Wall Street seemed happy in early trading, but there's still a lot that we don't know, guys.

Travis Hoium: Lou, that is the thing here, is if you squint, some of this makes a little bit of sense. But then you look at the structure: 50/50 deal. Stripe is buying PayPal and not can't exactly fold it into your current business, at least seamlessly. This also puts Stripe in a little bit of a strange position because a lot of the payment companies have built on top of Stripe, and now you're a competitor with PayPal. What should we think about this strategically, and how does the private equity piece of this play into it in your mind?

Lou Whiteman: A lot of thoughts here. For once, so Stripe is building their own PayPal. I guess they don't worry about the competition as much as I do. I think you're right. I think that would be an awkward conversation, but they either feel like they have to get there, so they just need to, or they're not worried about that. Here's the thing. There is value in PayPal. There really is. It's a good brand. I don't particularly like the stock. I don't think this is going to work. For one thing, you always, with these things, somebody leaked it. Who leaked it? That's the acquirer who leaked it. The offer was made a month ago or so. This is [OVERLAPPING].

Travis Hoium: That was the other thing that stuck out to me is it's apparently been on the table for a while.

Lou Whiteman: Yes. This is trying to light a fire under PayPal to get a response. Here's the thing. The value in PayPal for me right now is their cash flow, 6 billion of free cash flow. This is a mature company. This is a company that I don't think has a natural pathway for growth. It makes sense to take it private. The advent side of this deal makes all the sense of the world. Use that cash flow to pay down the debt you take on and create value that way. That's just private equity 101? There's a tension here, though. Because a private equity firm has a different motivation and different set of goals than a growthy fintech. This 50/50 partnership, if done right, I guess, is possible.

But there is some inherent tension of running it for Advent's needs versus running it for whatever reason Stripe thinks they need it. It's not impossible, but there's a lot of ways you can go wrong. I think PayPal will reject this. The other thing to note here is because they're such a mature company, about 75% of their ownership is institutional. I'll be honest with you, if I was sitting at that desk, I don't want to own PayPal personally, but if I was one of those institutional holders and I was looking at that cash flow, I would want at least 80. It starts with 80. I don't think, and I could be way off here, but I don't think for the people who matter — if the shareholders that could pressure PayPal to the table — I think there's still a long way to go before this makes sense.

Travis Hoium: Lou, I wanted to ask about this: would be a private company being involved in buying a public company, which means that, in theory, unless they're going to go public through the back door of buying PayPal, which I don't think is probably the case. Like Rachel said, $160 billion valuation in private market, but that's private markets, and a lot of these companies, PayPal, Advent have taken it on the chin over the past year or so. That number may not actually be what the market is going to bear. They're going to have to come up with the capital. I think the reports are they make a couple billion dollars in free cash flow. I have seen numbers that almost all of this deal could be funded with debt through that private equity piece.

What I guess I worry about with a company like Stripe is this was supposed to be one of the hot fin techs, one of the great IPOs potentially coming to the market, and now you're looking at potentially levering up a business I don't know if it's fundamentally in decline, but there's at least a lot of questions about how profitable these payment infrastructure companies are going to be in the future. Is that a massive risk to think about? Stripe is just making a last-gasp effort to grow the business when there's not a lot of growth necessarily left in the core business.

Lou Whiteman: If Stripe is public, that would be a big worry of mine. I think another way of saying what you're saying is that I don't want their cash to go to just paying off the debt if they have opportunities to grow. The thing is, again, PayPal generates so much cash. I do think that whether it's Advent 100% or Stripe involved, I do think that the target cash flows can basically cover the debt or go a long way for there. I think it is more what can we partner with? How can we make this synergistic? But look, that $160 billion number, that is great until you have to try to deploy it. There's a lot of great reasons to be a private company, but one of the great things about being a public company is price discovery. There are millions of people giving their opinion every day on what the value of your shares are versus just a couple of people desperate to get in and a couple of employees desperate to get out. You tend to have higher valuations in private companies for that reason.

This might be more intriguing if they were trying to use it as some crazy way to go public, where they are just putting their arguably overvalued shares to work to swallow this up and generate that cash flow. That might be a neater deal. Then we're talking like Rocket Lab/Iridium, where a young growth company is buying a cash stream. This is just a convoluted mess right now. I see a world where PayPal is taken private. I think it makes a lot of sense in a PE portfolio. The Stripe element, I think they have to go significantly higher to make this work. I could be wrong here, but I do think that, and if so, how far can Stripe go?

Travis Hoium: Definitely a lot that we'll be covering in the future, because PayPal's been in one of these companies that looks like a value stock for a very long time, but the stock just hasn't worked for investors, and maybe this is the best path out. When we come back, we're going to talk about Johnson and Johnson's earnings. You're listening to Motley Fool Hidden Gems Investing.

ADVERTISEMENT: In 2026, I've been trying to improve my health, but here's the thing I found: if you're not tracking your blood work, you're basically flying blind. That's why I'm excited to partner with Rythm. Rythm is the world's easiest blood test to help you learn what's happening inside your body. Takes about 2 minutes at home, no needles, just a sleek and painless collection device that sticks on your arm. Once your blood is collected, you put the sample in the package that Rythm provides, and they will even arrange to have it picked up from your front door. I did my first test about a month ago. The Rythm kit came in the mail. I drew my blood in about 2 minutes. Couldn't be easier. The results were live in about two days, and the portal makes it easy to understand what's going on. They've even got an AI health coach to help explain your results and recommend actions. Since I got my labs, I've changed the way I've eaten. Pounds are starting to come off, and it's easy to determine if something like a GLP one is right for you. I'm not one to run to the doctor, so the fact that I can do this at home and get fast results is what has me hooked, and my second kit is already on the way. Rythm is only $79 per month, a fraction of traditional lab testing, ships right to your door, and you can cancel anytime. Right now, Rythm is offering our listeners 15% off for your first month and free shipping at rhythm.com slash FOOL. That's Rythm with one H, R-Y-T-H-M rhythmhealth.com/fool for 15% off your first month and free shipping. Stop guessing, start testing rythmhealth.com/fool.

Travis Hoium: Welcome back to Motley Fool Hidden Gems Investing. Johnson and Johnson reported earnings this morning. Results look solid. At least premarket, the market didn't like what it saw, but Rachel, what do you think about the results from J&J?

Rachel Warren: A few key numbers here. Johnson and Johnson, they brought in just over $25 billion in revenue for the quarter. That was up about 7% from a year ago, adjusted earnings per share of $2.90. That was up about 5% year over year. Both on the top and bottom line, they beat Wall Street's expectations. Management actually hiked their full-year sales guidance to over $101 billion. That's putting Johnson & Johnson on track to cross the hundred-billion-dollar milestone for the very first time in roughly 140 years of company history, across all its iterations.

Now, what did investors like? There was a minor revenue miss in their medical device division, their med tech division. They saw a slight drop in sales for their Abiomed heart Pumps. But I think also we're seeing some hyperfixation on short-term patent anxieties. Now, this is something that flicks the life cycle of every pharmaceutical company, even the biggest and best in the world. For a long time, they have generated tremendous growth from their blockbuster drugs to Alora. That is a drug that is now seeing a lot of competition from biosimilars, and so that's dragging down some of their legacy.

Now, I'm a long-term shareholder of Johnson and Johnson. If you're a long-term investor in this business, I think today's drop, at least in the early morning hours, this is short-term market noise. This is a business that has increased its payout for over six decades every single year in counting. They have a very diversified revenue engine. They have a lot of newer business additions as well from new blockbuster drugs, and they're rolling out their next Gem Blockbusters, no major patent risks until the early 2030s beyond Sta. A lot to like about this business.

Lou Whiteman: Rachel summed up pretty well. One note on the med tech business, and I think it's an interesting aspect. We don't think of healthcare as cyclical because people are always getting sick and always need to get better. But there is a cyclical element in here, and I think the med tech part yesterday we saw Intuitive Surgical down a lot and a lot of device companies and supply companies fall. HCA, the big public hospital chain, said the number of surgeries they performed in the quarter are down. To me, that says that whatever's going on in the med tech business, that isn't a J&J problem. That isn't anything specific to STEM. That's a macro problem. But it is, I think, as investors, that's just the cyclicality of healthcare. We don't want to get political here, but there are a lot of reasons why that surgeries may go down right now, from healthcare coverage to economic woes. We saw this in the pandemic, where surgeries just went down. That's probably the most obvious example. But I think for J&J, it's investors and Intuitive Surgical, too. I don't think there's anything to worry about when you see it affecting everybody, but it is just an interesting odd thing. I don't think we think with healthcare is that there is a cyclicality.

Travis Hoium: You would think that raising guidance, I think both on the top and bottom line, would be a good thing for a stock, but investors don't seem to think that at least early in trading shares are down about 0.6% as we're recording. We'll see where this one goes in the future. When we come back, we're going to talk about the drama that Uber is having in Washington, D.C. You're listening to Motley Fool Hidden Investing.

ADVERTISEMENT: What if the drink's pink and the cream's pink? Chill. It's no big deal. Just get the new strawberry candy plus rape from our new McCafe Summer drinks range. Now at McDonald's. Available until 7 September. Price and participation may vary. Frap is not available on delivery. Subject to availability. Everyone's talking about AI, but here's the insider tip. Business success hinges on people who know how to lead projects, align teams, and deliver now more than ever. The PMP certification, how the ambitious get ahead. Get PMP certified. Learn more at pmi.org.

Travis Hoium: Welcome to Motley Fool Hidden Gems Investing. We've talked a lot on this show, at least, especially on Wednesdays, about Uber autonomous vehicles and the future of that business long term. I'm a bull on Uber's case as the disruptor and the aggregator, but Lou, seems like they're taking a little bit of a different approach in D.C.

Lou Whiteman: They are not acting like a disruptor anymore, Travis. Uber is acting like a nervous dinosaur, a nervous incumbent, period.

Travis Hoium: I actually hate that you're making, I think, a compelling argument that that is the case.

Lou Whiteman: I'm not going to rub it in your face and say we were talking about this a year ago, Travis. We should have seen this coming. But look, the good news here is that for all of us is that I think the age of autonomy has arrived. Companies tend to act as partners and be friendly and work together when technology is experimental, when we're just trying to figure it out. The second that it has arrived, that's when the knives come out, and they fight, and that is really what's going on. In Washington, specifically, Waymo would like to just operate Waymo. Uber opposes the bill that would allow this, and they have been lobbying instead for a system that will require Robotaxis to operate on a ride-hailing network that also uses human drivers. Do you catch that? They would like Waymo to have to go to an existing third-party network. I don't know who that would be. In Lyft, maybe, but I think we know what they're trying to do.

Here's the thing. Uber doesn't have a driverless solution. That was their choice, and it probably was a good choice, considering the money that they'd have to spend, but their product at this moment is their inventory of customers. It is very important for them to make sure that that product is exposed to the surface that you can't bypass that product, 15 years ago, Uber was the disruptor. They were the ones trying to tear down regulations. They were the ones trying to rip out the rules. Now they are the defenders of the horse carriage in the age of the automobile. Their goal is to use regulatory, capture regulation to slow down the transition, not disrupt the status quo that works pretty well for them. It will work for a while. It's a very compelling story. Uber is up there talking about all of the jobs that will be lost, which is really funny if you look back at their narrative over the years. But it won't last forever, and as an investor, I think we have to be aware of that.

Travis Hoium: Yes, Rachel, the interesting thing here is, it seems like Uber is not opposed to autonomous vehicles. They just want to make sure that their business model is still intact and is, like Lou said, not disrupted. The other angle to this, and the thing that we've talked about a couple of different times, is their strategy is to basically arm as many autonomous vehicle companies as possible. We can get to Lucid and the challenges that they've had this week, at least in the market. But that's one of the companies that they helped fund. Lucid is working with Nuro to bring autonomous vehicles to market. Uber is going to be one of the buyers of those vehicles. That's not the only company. There's a half dozen or a dozen companies. But none of them are really hitting market at scale yet. I think that seems to be the challenge for Uber is you can't use that network to build the autonomous vehicle fleet if the fleet isn't quite ready to hit the road.

Rachel Warren: I think that's right. There's a couple of things to look at here. First, just taking a step back, you look at Uber's history, which Lou touched upon briefly. Over a decade ago, Uber won the ride-sharing war by using aggressive lobbying to crush a lot of the local tax monopolies. Today, they're facing a different threat from driverless cars. Maybe the old playbook isn't working, and as Lou said, there is a lot of lobbying happening on the Hill, trying to block standalone AVs from taking over, pushing for laws that would force taxes to work on these hybrid networks. There was documentation reporting that came out that showed that, in New Jersey, for example, Uber tried to pass a rule that would force any driverless company to have human drivers handle 85% of their. We saw Uber, Waymo, and their partnership pilot in Phoenix last month.

Uber used to pride itself on being this asset-light tech company that didn't own cars. They have invested billions to buy the driverless hardware, invest in EV companies, like you noted. I mean, hundreds of millions of dollars invested in Lucid. Uber owns, I believe, an 11.5% stake. They plan to buy thousands of their electric vehicles. We saw these viral rumors of Lucid bankruptcy, and then Lucid's executives broke their silence and said, these rumors are completely false. I think it shows how fast Lucid is burning through cash that there was such a deep market panic. But you look at Uber; they have scattered hundreds of millions of dollars across different partners. Lucid, Neuro Cruz, the list goes on, but none of those bets are really scaling yet.

Meanwhile, Waymo is dominating the AV space. They've cleared over 500,000 commercial trips every single week at this point, probably more by now. That's a number that came out a number of months ago. Uber, I think, is still trying to catch up. I do think there's a very real concern here for Uber. I think we're seeing those cracks start to show. It doesn't mean they can't catch up, but I think that they're realizing that the strategies that worked a decade ago are not going to work in the current age, and I think that's what they're trying to figure out.

Lou Whiteman: I got bad news for Lucid holders because I know we're supposed to believe that, a lot like other electric vehicle companies, they are this close to an autonomous solution. As you say, Uber and Lucid are already partners are already working together. Right now today, Uber could use one third of the cash sitting in their bank to just buy Lucid. If Lucid had a valid or anywhere close to happening autonomous project, that is the easy button for Uber. Instead, they're off maybe buying other delivery companies. I think that says all we need to know. I don't want to hear a single bit of hype about Lucid's autonomy being anywhere close; if it was, they'd be a subsidiary of Uber.

Travis Hoium: It will be very interesting to watch this because the vehicles like Lucid are hitting the road. I'm in the Minneapolis area. This was often seen as one of the last places that was going to get autonomous vehicles. My wife, once or twice a week, says, Hey, I saw another Waymo downtown. I know that May Mobility is here testing in one of the suburbs that we live near. Slowly but surely, we're getting to the business model that the future is going to look like, but it seems like Uber is now on a little bit of a defensive position. As an investor, I want to be playing offense, not defense. That does make me a little bit nervous. Hopefully, we'll learn more about that in the future.

As always, people on the program may have interest in the stocks they talk about, and The Motley Fool may have one more recommendation, so don't buy yourselves based solely on what you hear. All personal finance content follows The Motley Fool's editorial standards, and it's not approved by advertisers. Advertisements are sponsored content and provided for informational purposes only. See our full advertising disclosure. Please check out our shown. For Lou Whitman, Rachel Warren, and Kristi Waterworth, behind the glass. I'm Travis Hoium. Thanks for listening. We'll see you here tomorrow.

Lou Whiteman has positions in Rocket Lab. Rachel Warren has positions in Johnson & Johnson. Travis Hoium has positions in Lyft, PayPal, and Uber Technologies. The Motley Fool has positions in and recommends HCA Healthcare, Intuitive Surgical, Lyft, PayPal, Rocket Lab, and Uber Technologies. The Motley Fool recommends Johnson & Johnson and recommends the following options: long January 2028 $520 calls on Intuitive Surgical, short January 2028 $530 calls on Intuitive Surgical, and short September 2026 $47.50 calls on PayPal. The Motley Fool has a disclosure policy.